Are you Dr. Cardozo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
345 E 37th St
Suite 307
New York, NY 10016Phone+1 212-532-5355Fax+1 212-683-8057
Summary
- Dr. Timothy Cardozo, MD is a board certified dermatologist in New York, New York. He is currently licensed to practice medicine in New York. He is an Associate Professor at New York.
Education & Training
- New York University School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2002 - 2025
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- In situ cell-surface conformation of the TCR-CD3 signaling complex.Aswin Natarajan, Yogambigai Velmurugu, Manuel Becerra Flores, Fatoumatta Dibba, Saikiran Beesam
EMBO Reports. 2024-12-01 - Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response.Mohammad Arif Rahman, Massimiliano Bissa, Hanna Scinto, Savannah E Howe, Sarkis Sarkis
Nature Communications. 2024-10-22 - Publisher Correction: Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques.Mohammad Arif Rahman, Massimiliano Bissa, Isabela Silva de Castro, Sabrina Helmold Hait, James D Stamos
Nature Microbiology. 2023-08-01
Press Mentions
- Experimental Decoy Drug Tricks Coronavirus, Then Destroys ItDecember 7th, 2022
- Are COVID-19 Vaccine Trials in Violation of Ethical Norms by Not Disclosing ADE Risks?May 25th, 2021
- COVID Vaccine Can Worsen Disease; Mainstream Study; Not on the Evening NewsMay 11th, 2021
- Join now to see all
Grant Support
- Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apexNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2026
- Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apexNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2026
- Rescue of Autoimmune-Associated Long QT Syndrome by Decoy PeptidesNARROWS INSTITUTE FOR BIOMEDICAL RES INC2022–2026
- Rescue of Autoimmune-Associated Long QT Syndrome by Decoy PeptidesNARROWS INSTITUTE FOR BIOMEDICAL RES INC2022–2026
- Discovery of novel openers of the understudied human drug target Kir6.1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2025